Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,000
Closed -$747K 1401
2024
Q2
$747K Sell
2,000
-47
-2% -$15.9K 0.02% 599
2024
Q1
$710K Buy
+2,047
New +$776K 0.04% 369
2023
Q2
Sell
-6,100
Closed -$2.96M 838
2023
Q1
$2.96M Buy
6,100
+5,000
+455% +$2.47M 0.1% 168
2022
Q4
$563K Buy
1,100
+400
+57% +$210K 0.03% 488
2022
Q3
$340K Buy
+700
New +$340K 0.02% 592
2022
Q2
Sell
-1,500
Closed -$653K 1383
2022
Q1
$653K Sell
1,500
-10,400
-87% -$4.35M 0.02% 604
2021
Q4
$5.52M Buy
+11,900
New +$5.27M 0.08% 199
2021
Q3
Sell
-8,700
Closed -$3.85M 1450
2021
Q2
$3.85M Buy
8,700
+7,100
+444% +$3.1M 0.07% 254
2021
Q1
$671K Sell
1,600
-6,800
-81% -$2.71M 0.01% 926
2020
Q4
$3.45M Buy
+8,400
New +$3.49M 0.09% 235
2020
Q3
Sell
-400
Closed -$155K 2253
2020
Q2
$155K Buy
+400
New +$150K ﹤0.01% 1781
2018
Q4
Sell
-17,200
Closed -$5.82M 1492
2018
Q3
$5.82M Buy
17,200
+8,600
+100% +$2.79M 0.11% 162
2018
Q2
$2.56M Sell
8,600
-400
-4% -$117K 0.05% 359
2018
Q1
$2.42M Buy
+9,000
New +$2.44M 0.04% 475

Other funds holding HUM

Paloma Partners's HUM Position: Q4 2024 in Review

Paloma Partners sold out of Humana (HUM) in Q4 2024, closing a stake of 853 shares — an estimated $270K sold.

Paloma Partners first reported a position in HUM in Q2 2013 and held it in 36 quarters. The position peaked at $12.7M in Q1 2017. 876 funds tracked by Wall St. Rank hold HUM as of Q4 2024.

  • Paloma Partners reported no remaining Humana position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 853 Humana shares in Q4 2024, an estimated $270K.
  • Paloma Partners first reported a position in Humana in Q2 2013 and held it in 36 quarters.
  • Paloma Partners's Humana position peaked at $12.7M in Q1 2017.
  • 876 funds tracked by Wall St. Rank held Humana as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.